The abstract is read at the publisher; the summary is JClub's.
γδ CAR-T cells expressing PSCA-8t28z show comparable cytotoxicity to αβ CAR-T cells but distinct signaling and metabolism, including lower glycolysis/oxidative phosphorylation capacity.
- Why it matters: Most PSCA-targeting CARs are optimized for αβ T cells, yet γδ T-cell therapies face different biology that may limit performance without tailored CAR signaling.
- What they did: The study compared γδ and αβ T cells transduced with PSCA-8t28z using system-level phosphoproteomics, finding 307 differential phosphosites and validating glycolytic/oxidative and AP-1 activation differences.
- The result: TXNIP emerged as a potential actionable metabolic target, and a new synthetic costimulatory receptor that potentiates AP-1 improved in vivo persistence, supporting cell type-specific CAR engineering.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.